View Item 

Show simple item record

Potential role of PC-1 expression and pyrophosphate elaboration in the molecular etiology of the FGFR-associated craniosynostosis syndromes

dc.contributor.authorHatch, N. E.en_US
dc.date.accessioned2010-06-01T20:32:35Z
dc.date.available2010-06-01T20:32:35Z
dc.date.issued2007-05en_US
dc.identifier.citationHatch, NE (2007). "Potential role of PC-1 expression and pyrophosphate elaboration in the molecular etiology of the FGFR-associated craniosynostosis syndromes." Orthodontics & Craniofacial Research 10(2): 53-58. <http://hdl.handle.net/2027.42/73652>en_US
dc.identifier.issn1601-6335en_US
dc.identifier.issn1601-6343en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73652
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17552941&dopt=citationen_US
dc.format.extent509780 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2007 The Author. Journal compilation 2007 Blackwell Munksgaarden_US
dc.subject.otherCraniosynostosisen_US
dc.subject.otherFibroblast Growth Factoren_US
dc.subject.otherMineralizationen_US
dc.subject.otherOsteoblasten_US
dc.subject.otherPC-1en_US
dc.subject.otherPyrophosphateen_US
dc.titlePotential role of PC-1 expression and pyrophosphate elaboration in the molecular etiology of the FGFR-associated craniosynostosis syndromesen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelDentistryen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid17552941en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73652/1/j.1601-6343.2007.00387.x.pdf
dc.identifier.doi10.1111/j.1601-6343.2007.00387.xen_US
dc.identifier.sourceOrthodontics & Craniofacial Researchen_US
dc.identifier.citedreferenceDe Moerlooze L, Dickson C. Skeletal disorders associated with fibroblast growth factor receptor mutations. Curr Opin Genet Dev 1997; 7: 378 – 85.en_US
dc.identifier.citedreferenceOrnitz DM, Marie PJ. FGF Signaling in endochondral and intramembranous bone development and human genetic disease. Genes Dev 2002; 16: 1446 – 65.en_US
dc.identifier.citedreferenceMarie PJ. Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 2003; 316: 23 – 32.en_US
dc.identifier.citedreferenceDePollack C, Renier D, Hott M, Marie P. Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis). J Bone Min Res 1996; 11: 401 – 7.en_US
dc.identifier.citedreferenceLomri A, Lemonnier J, Hott M, Perseval N, Lajeunie E, Munnich A et al. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. J Clin Investig 1998; 101: 1310 – 7.en_US
dc.identifier.citedreferenceFragale A, Tartaglia M, Bernardini S, Michela de Stasio AM, di Rocco C, Velardi F et al. Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. Am J Path 1999; 154: 1465 – 77.en_US
dc.identifier.citedreferenceRice D, Kim H, Thesleff I. Apoptosis in murine calvarial bone and suture development. Eur J Oral Sci 1999; 107: 265 – 75.en_US
dc.identifier.citedreferenceDry GM, Yasinskaya YI, Williams JK, Ehrlich GD, Preston RA, Hu FZ et al. Inhibition of apoptosis: a potential mechanism for syndromic craniosynostosis. Plas Reconstr Surg 1999; 107: 425 – 32.en_US
dc.identifier.citedreferenceLemmonier J, Delannoy P, Hott M, Lomri A, Modrowski D, Marie PJ. The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation. Exp Cell Res 2002; 256: 158 – 67.en_US
dc.identifier.citedreferenceLemonnier J, Hay E, Delannoy P, Fromigue O, Lomri A, Modrowski D et al. Increased osteoblast apoptosis in Apert craniosynostosis: role of protein kinase C and interleukin-1. Am J Path 2001; 158: 1833 – 42.en_US
dc.identifier.citedreferenceMansukhani A, Bellosta P, Sahni M, Basilico C. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Bio 2000; 149: 1297 – 308.en_US
dc.identifier.citedreferenceRegister TC, Wuthier RE. The effect of pyrophosphate and two diphosphonates on 45 Ca and 32 Pi uptake and mineralization by matrix vesicle-enriched fractions and by hydroxyapatite. Bone 1985; 6: 307 – 12.en_US
dc.identifier.citedreferenceAnderson HC, Sipe JB, Hessle L, Dhamyamraju R. Atti E. Camacho NP et al. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Path 2004; 164: 841 – 7.en_US
dc.identifier.citedreferenceTerkeltaub R, Rosenbach M, Fong F, Goding J. Causal link between nucleotide pyrophosphohydrolase over activity and increased intracellular inorganic pyrophosphate generation demonstrated by transfection of cultured fibroblasts and osteoblasts with plasma cell membrane glyoprotein-1. Arthrit Rheum 1994; 37: 934 – 41.en_US
dc.identifier.citedreferenceFleisch H, Straumann F, Schenk R, Bisaz S, Allgower M. Effect of condensed phosphates on calcification of chick embryo femurs in tissue culture. Am J Physiol 1966; 211: 821 – 5.en_US
dc.identifier.citedreferenceJohnson K, Moffa A, Chen Y, Prizker K, Goding J, Terkeltaub R. Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells. J Bone Min Res 1999; 14: 883 – 92.en_US
dc.identifier.citedreferenceJohnson KA, Hessle L, Vaingankar S, Wennerg C, Mauro S, Narisawa S et al. Osteoblast tissue-nonspecific alkaline phosphatase antagonizs and regulates PC-1. Am J Physiol Int Comp Physiol 2000; 279: 1365 – 77.en_US
dc.identifier.citedreferenceJohnson K, Goding J, Van Etten D, Sali A, Hu S, Farley D et al. Linked deficiencies in extracellular PPi and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression. J Bone Min Res 2003; 18: 994 – 1004.en_US
dc.identifier.citedreferenceHessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW et al. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Nat Acad Sci 2002; 99: 9445 – 9.en_US
dc.identifier.citedreferencePendleton A, Johnson MD, Hughes A, Gurley KA, Ho AM, Doherty M et al. Mutations in ANKH cause chondrocalcinosis. Am J Hum Gen 2002; 71: 933 – 40.en_US
dc.identifier.citedreferenceReichenberger E, Tiziani V, Watanabe S, Park L, Ueki Y, Santanne C et al. Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Gen 2001; 68: 1321 – 6.en_US
dc.identifier.citedreferenceNurnberg P, Thiele H, Chandler D, Hohne W, Cunningham ML, Ritter H et al. Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. Nat Gen 2001; 28: 37 – 41.en_US
dc.identifier.citedreferenceHo AM, Johnson MD, Kingsley DM. Role of the mouse ank gene in control of tissue calcification and arthritis. Science 2000; 289: 265 – 70.en_US
dc.identifier.citedreferenceSohn P, Crowley M, Slattery E, Serra R. Developmental and TGF- β mediated regulation of Ank mRNA expression in cartilage and bone. Osteoarthr Cart 2002; 10: 482 – 90.en_US
dc.identifier.citedreferenceHatch NE, Nociti F, Swanson E, Bothwell M, Somerman M. FGF2 alters expression of the pyrophosphate/phosphate regulating proteins, PC-1, ANK, TNAP, in the calvarial osteoblastic cell line, MC3T3E1(C4). Conn Tiss Res 2005; 46: 184 – 92.en_US
dc.identifier.citedreferenceSudo H, Kodama H, Amagai Y, Yamamoto S, Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Bio 1983; 96: 191 – 8.en_US
dc.identifier.citedreferenceWang D, Christensen K, Chawla K, Xiao G, Krebsbach P, Franceschi R. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Min Res 1999; 14: 893 – 903.en_US
dc.identifier.citedreferenceKreiborg S. Crouzon syndrome: a clinical and roentgencephalometric study. Scan J Plast Reconstr Surg, 1981; 18 ( Suppl. ): 1 – 198.en_US
dc.identifier.citedreferenceChen L, Li D, Li C, Engel A, Deng CX. A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Bone 2003; 33: 169 – 78.en_US
dc.identifier.citedreferenceEswarakumar VP, Horowitz MC, Locklin R, Morriss-Kay GM, Lonai P. A gain of function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc Nat Acad Sci 2004; 101: 12555 – 60.en_US
dc.identifier.citedreferenceJohnson K, Hashimoto S, Lotz M, Pritzker K, Goding J, Terkeltaub R. Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathgenic factor for knee meniscal cartilage matrix calcification. Arthritis Rheum 2001; 44: 1071 – 81.en_US
dc.identifier.citedreferenceJohnson K, Terkeltaub R. Upregulated ank expression in osteoarthritis can promote both chondrocyte MMP-13 expression and calcification via chondrocyte extracellular PPi excess. Osteoarthr Cart 2004; 12: 321 – 35.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1601-6343.2007.00387.x.pdf
Size:
497.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.